As India enters the 1st phase of its vaccination drive, Congress continues to raise alarm over the safety of Bharat Biotech’s Covaxin, a drug approved by DCGI even though it has not revealed the mandatory Phase 3 trials results.
Concerned over not having the option to choose between Covaxin and Covishield, senior party leader Manish Tewari said, "If the vaccine is so safe & reliable & efficacy of the vaccine is beyond question then how is it that not a single functionary of the government has stepped forward to get themselves vaccinated as it has happened in other countries around the world?"
Congress has raised objection over the approval of Covaxin and its subsequent roll out. Though the Congress ruled states have joined the vaccination drive, barring Chhattisgarh, the states have left the onus of the safety of the vaccines on the Centre. Chhattisgarh will administer only Oxford-AstraZeneca’s Covishield to its populace.